Physician; MD​/DO - Hematology and Oncology - Orleans, LA

Position: Physician (MD/DO) - Hematology and Oncology - $346,000 to $638,000 per year in New Orleans, LA
Doctor of Medicine | Hematology and Oncology

Location:

New Orleans, LA

Employer:

Curative

Pay:  $346,000 to $638,000 per year

Start Date:

ASAP

About the Position
Leukemia & Bone Marrow Hematology/Oncology Faculty | New Orleans, Louisiana

Join Tulane University School of Medicine as a Hematology and Oncology faculty member in New Orleans, where research leadership, clinical care, and education are deeply integrated. This role is designed for a physician specializing in Leukemia or Bone Marrow who wants to lead impactful clinical research while maintaining a meaningful clinical and teaching presence within a respected academic program.

Practice Details

Academic-based Hematology and Oncology faculty position with a focus on Leukemia or Bone Marrow
Opportunity to serve as a leader in translational and clinical research
APP support for both clinic and inpatient rounding
Active teaching role with fellows, residents, and medical students
At least 50% protected time dedicated to research and academic pursuits
Clinical and Research Trials

This position offers an unprecedented opportunity to lead research that is truly pioneering within the field. You will have the chance to position yourself at the forefront of your discipline, strengthen your academic portfolio, and open doors for future leadership and research appointments.

Trial 1:
Phase III study comparing two treatment arms in Acute Myeloid Leukemia (AML) patients who have failed 2-4 previous induction therapies, focusing on relapsed or refractory cases with a 1:1 enrollment ratio
Trial 2:
Comparison of LOXO-305 versus idelalisib plus rituximab or bendamustine plus rituximab in previously treated CLL or SLL patients who have used a BTK inhibitor
Trial 3:
Evaluation of blinatumomab in treating CD19-positive mixed phenotypic acute leukemia (MPAL) in patients with relapsed or refractory disease or measurable residual disease (MRD)
Trial 4:
Two-part study of venetoclax with AZA and CC-486 in dose confirmation and dose-finding stages to establish the recommended Phase 3 dose for each combination
Trial 5:
Assessment of galinpepimut-S (GPS) versus best available therapy (BAT) to improve survival in AML patients in second or subsequent complete remission (CR2 or CRp2)
Candidate Requirements

Board-Certified or Board-Eligible in Hematology and Oncology
Subspecialty focus or experience in Leukemia or Bone Marrow Transplant
Strong interest in clinical trial leadership, academic publishing, and translational research
Commitment to teaching and mentoring within a multidisciplinary academic environment
About Tulane University & New Orleans

Tulane University School of Medicine offers a collaborative academic environment with growing research infrastructure and a strong regional impact. Located in New Orleans, faculty enjoy access to an international airport, nationally recognized universities, professional sports, and world-renowned dining and cultural experiences. The city's blend of historic character, modern healthcare facilities, and vibrant community life makes it a compelling place to advance an academic career.